We fight to improve the lives
of everyone affected by epilepsy

Warning message

  • This article was published in July 2017. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in December 2016. The information may be out of date. Please check our epilepsy information or our site A-Z.

Stories about epilepsy medicines

Some epilepsy medicines “cannot be stockpiled”, NHS list reveals

9 Apr 2019

On 3 April, BBC Newsnight reported that some medicines, including some for epilepsy, bipolar disorder and neuropathic pain, cannot be stockpiled.

This comes after the Health Secretary Matthew Hancock said in parliament that medical suppliers had been asked to stockpile an extra six-weeks’ worth of medicines. This is to ensure medicine supply continues in all Brexit scenarios.

Topiramate may be linked to increased risk of birth defects in babies born to women taking the medicine

9 Jan 2018

TopirimateA new US study has found that taking the medicine topiramate during pregnancy may cause an increased risk of birth defects.

Topiramate is an epilepsy medicine sometimes used to treat generalised tonic-clonic seizures or focal seizures. This medicine can also be used for other conditions, such as bipolar disorder.

Government update to guidelines about switching between different forms of epilepsy medicines says prescribers should consider the individual’s concerns

1 Dec 2017

The government has added to its guidelines about switching between different forms of epilepsy medicines. The update says that prescribers need to take into consideration people’s thoughts and concerns.

Pfizer and Flynn Pharma fined a record £90 million for ‘excessive and unfair’ price hikes for phenytoin

7 Dec 2016

Pharmaceuticals company Pfizer, which manufactures the epilepsy medicine phenytoin sodium capsules, has been fined a record £84.2 million by the Competition and Markets Authority (CMA). The company has been found to be breaking competition law by charging what the CMA said were 'excessive and unfair' prices in the UK for the medicine.

Pages

Subscribe to epilepsy medicines